[Controlled vascular training in IIb peripheral arterial occlusive disease: additive effect of intravenous PGE1 versus intravenous pentoxifylline during training].
An intensive 4-week vascular training (patients with PAOD IIb) leads to an effective amelioration of painfree walking distance (+120%). Additive i.v. Pentoxifylline was not more effective (+105%) whereas PGE1 showed a remarkable increase (+605%). After one year the results in all groups diminished: training group: +30%, Pentoxifylline group: +30%, PGE1 group: +149%.
Scheffler
P
P
Angiologische Ambulanz, Bliestal Kliniken, Universitätskliniken Homburg.
de la Hamette
D
D
Müller
H
H
D000527:Alprostadil / Q000008:administration & dosage*; D001157:Arterial Occlusive Diseases / Q000534:rehabilitation*; D003131:Combined Modality Therapy; D005081:Exercise Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010431:Pentoxifylline / Q000008:administration & dosage*; D016138:Walking
D000527:Alprostadil; D010431:Pentoxifylline
Gezieltes Gefässtraining bei PAVK IIb: Additiver Effekt von i.v. PGE1 versus i.v. Pentoxifyllin während des Trainings.